1802632-22-9 Usage
Uses
Used in Pharmaceutical Industry:
2-(tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol is used as a potential pharmaceutical agent for its unique combination of functional groups, which may offer novel therapeutic properties and mechanisms of action. 2-(tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol's solubility and steric hindrance could be advantageous in drug design and delivery, potentially leading to improved pharmacokinetics and pharmacodynamics.
Used in Cosmetics Industry:
In the cosmetics industry, 2-(tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol may serve as an active ingredient or additive, leveraging its solubility and functional groups to enhance product performance. Its potential applications could include skin care, hair care, or other personal care products, where it may contribute to improved efficacy, stability, or sensory attributes.
Used in Materials Science:
2-(tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol's unique properties may also find applications in materials science, where it could be utilized in the development of new materials with specific properties. Its solubility in organic solvents and steric hindrance could be advantageous in the synthesis of polymers, coatings, or other materials with tailored characteristics for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1802632-22-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,8,0,2,6,3 and 2 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1802632-22:
(9*1)+(8*8)+(7*0)+(6*2)+(5*6)+(4*3)+(3*2)+(2*2)+(1*2)=139
139 % 10 = 9
So 1802632-22-9 is a valid CAS Registry Number.
1802632-22-9Relevant academic research and scientific papers
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease
Catalano, Susan M.,Huang, Yaodong,Izzo, Nicholas J.,Labarbera, Kelsie M,Limegrover, Colleen S.,Look, Gary C.,Ni, Zhi-Jie,Rehak, Courtney,Rishton, Gilbert M.,Wang, Yingcai,Wu, Xiaodong,Yurko, Raymond,Zhang, Jason
, p. 1389 - 1395 (2021/08/31)
An unbiased phenotypic neuronal assay was developed to measure the synaptotoxic effects of soluble Aβ oligomers. A collection of CNS druglike small molecules prepared by conditioned extraction was screened. Compounds that prevented and reversed synaptotox
ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
-
Paragraph 0533; 0534; 0545, (2015/09/23)
Isoindoline sigma-2 receptor antagonist compounds, pharmaceutical compositions comprising such compounds, and methods for inhibiting Abeta- associated synapse loss or synaptic dysfunction in neuronal cells, modulating an Abeta-associated membrane trafficking change in neuronal cells, and treating cognitive decline associated with Abeta pathology are provided.
